---
figid: PMC4621122__zjv9990908910008
figlink: /pmc/articles/PMC4621122/figure/F8/
number: FIG 8
caption: Hypothesized model for E4-ORF1-induced constitutive Myc protein expression
  mediated by EGFR, InsR/IGF1R, and PI3K. (A) In normal MCF10A cells, EGFR and Dlg1
  form a Dlg1:EGFR complex at the plasma membrane. When activated by ligand, EGFR
  autophosphorylates tyrosine (Y) residues that directly mediate Ras/Mek/Erk signaling
  (black) and also those that augment Ras/Mek/Erk signaling (white). InsR/IGF1R activated
  by ligand specifically downregulates EGFR autophosphorylation on white Y residues
  that augment Ras/Mek/Erk signaling. (B) E4-ORF1 assembles two different protein
  complexes at the plasma membrane to activate three separate signaling pathways.
  E4-ORF1 forms the E4-ORF1:Dlg1:EGFR:InsR:IGF1R quinary complex by binding to the
  Dlg1:EGFR complex and promoting EGFR dimerization and EGFR association with InsR
  and IGF1R. In the quinary complex, the E4-ORF1 D2 element promotes EGFR autophosphorylation
  on black Y residues to activate Ras/Mek/Erk signaling, whereas the E4-ORF1 PBM via
  binding to Dlg1 enhances the latter signaling by antagonizing InsR/IGF1R-mediated
  suppression of EGFR autophosphorylation on white Y residues. An additional consequence
  of E4-ORF1 forming the quinary complex is activation of InsR/IGF1R (denoted by asterisks)
  and undetermined downstream signaling pathways. E4-ORF1 also binds both Dlg1 and
  PI3K to form the Dlg1:E4-ORF1:PI3K ternary complex, which activates the PI3K/Akt/mTOR
  pathway. (C) The three signaling pathways (Ras/Mek/Erk, InsR/IGF1R, and PI3K/Akt/mTOR)
  activated by E4-ORF1 converge in the nucleus to promote constitutive Myc expression,
  which enhances Ad replication by ensuring the formation of sufficient quantities
  of E4-ORF1:Myc complexes to stimulate anabolic glucose metabolism and nucleotide
  biosynthesis. See the text for details about steps 1 to 8 in the model.
pmcid: PMC4621122
papertitle: Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like
  Growth Factor Receptors To Mediate Constitutive Myc Expression.
reftext: Kathleen Kong, et al. J Virol. 2015 Nov 1;89(21):10774-10785.
pmc_ranked_result_index: '61885'
pathway_score: 0.9206912
filename: zjv9990908910008.jpg
figtitle: Hypothesized model for E4-ORF1-induced constitutive Myc protein expression
  mediated by EGFR, InsR/IGF1R, and PI3K
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4621122__zjv9990908910008.html
  '@type': Dataset
  description: Hypothesized model for E4-ORF1-induced constitutive Myc protein expression
    mediated by EGFR, InsR/IGF1R, and PI3K. (A) In normal MCF10A cells, EGFR and Dlg1
    form a Dlg1:EGFR complex at the plasma membrane. When activated by ligand, EGFR
    autophosphorylates tyrosine (Y) residues that directly mediate Ras/Mek/Erk signaling
    (black) and also those that augment Ras/Mek/Erk signaling (white). InsR/IGF1R
    activated by ligand specifically downregulates EGFR autophosphorylation on white
    Y residues that augment Ras/Mek/Erk signaling. (B) E4-ORF1 assembles two different
    protein complexes at the plasma membrane to activate three separate signaling
    pathways. E4-ORF1 forms the E4-ORF1:Dlg1:EGFR:InsR:IGF1R quinary complex by binding
    to the Dlg1:EGFR complex and promoting EGFR dimerization and EGFR association
    with InsR and IGF1R. In the quinary complex, the E4-ORF1 D2 element promotes EGFR
    autophosphorylation on black Y residues to activate Ras/Mek/Erk signaling, whereas
    the E4-ORF1 PBM via binding to Dlg1 enhances the latter signaling by antagonizing
    InsR/IGF1R-mediated suppression of EGFR autophosphorylation on white Y residues.
    An additional consequence of E4-ORF1 forming the quinary complex is activation
    of InsR/IGF1R (denoted by asterisks) and undetermined downstream signaling pathways.
    E4-ORF1 also binds both Dlg1 and PI3K to form the Dlg1:E4-ORF1:PI3K ternary complex,
    which activates the PI3K/Akt/mTOR pathway. (C) The three signaling pathways (Ras/Mek/Erk,
    InsR/IGF1R, and PI3K/Akt/mTOR) activated by E4-ORF1 converge in the nucleus to
    promote constitutive Myc expression, which enhances Ad replication by ensuring
    the formation of sufficient quantities of E4-ORF1:Myc complexes to stimulate anabolic
    glucose metabolism and nucleotide biosynthesis. See the text for details about
    steps 1 to 8 in the model.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - KRAS
  - PIK3R3
  - MAPK3
  - PIK3CD
  - MYC
  - PIK3R4
  - AKT2
  - NRAS
  - PIK3CA
  - DLG1
  - MAP2K2
  - PIK3CG
  - INSR
  - MAP2K1
  - AKT1
  - PIK3R6
  - MAPK1
  - HRAS
  - MTOR
  - PIK3R5
  - IGF1R
  - PIK3CB
  - AKT3
  - glucose
  - Cancer
  - Lung cancer
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Ras/Mek/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ras/Mek/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras/Mek/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Dlg1
  symbol: DLG1
  source: hgnc_symbol
  hgnc_symbol: DLG1
  entrez: '1739'
- word: Ras/Mek/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: InsR*
  symbol: INSR
  source: hgnc_symbol
  hgnc_symbol: INSR
  entrez: '3643'
- word: Ras/Mek/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras/Mek/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras/Mek/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K/Akt/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IGF1R*
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
